Search Results 391-400 of 14896 for alt

1. PRGN-3006 Adoptive Cellular Therapy for CD33-Positive Relapsed or Refractory AML, MRD Positive AML or Higher Risk MDS - Mayo Clinic

   - Alanine aminotransferase (AST) and aspartate aminotransferase (ALT) < 3.0 x ULN. - Ejection fraction measured by echocardiogram (ECHO) or multi gated ...

2. A Study of the Effectiveness and Safety of Targeted Delivery of Auto CD34+ Stem Cells into Heart Muscle for Improving Exercise Capacity in People with Angina Resistant to Treatment - Mayo Clinic

   Hepatic dysfunction as evidenced by elevated AST or ALT levels > 2.5 x ULN; Any previous transplant requiring immunosuppression; Disease state requiring ...

3. A Study to Evaluate Gemcitabine, Cisplatin, and Nab-Paclitaxel to Treat Patients with High-Risk Liver Bile Duct Cancer Before Surgery - Mayo Clinic

   AST and ALT ≤ 2.5 x ULN; and; Albumin ≥ 3 g/dl. Adequate renal function as evidenced by: Ccreatinine ≤ 1.5 x ULN. Male, or a non-pregnant and non ...

4. A Study of AFP464 for Treating Patients with Solid Tumors that are Metastatic or Resistant to Treatment, and Cannot Be Removed By Surgery - Mayo Clinic

   Total bilirubin ≤ upper limits of normal (ULN); Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ≤ 2.5 x ULN; Creatinine ≤ 1.25 x ULN. If ...

5. Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus-Host Disease (BMT CTN 1301) - Mayo Clinic

   Liver function: total bilirubin < 2x the upper limit of normal (unless elevated bilirubin is attributed to Gilbert's Syndrome) and alanine aminotransferase (ALT) ...

6. A Study to Determine the Safety, Tolerability and Pharmacokinetics of an Anti-PD-1 Monoclonal Antibody in Subjects With Advanced Malignancies - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 2.5 × ULN; for subjects with hepatic metastases, ALT and AST ≤ 5 × ULN;; Serum ...

7. A Study to Compare Tisagenlecleucel vs. Standard of Care in Adult Patients with Aggressive B-cell Non-Hodgkin Lymphoma - Mayo Clinic

   Alanine Transaminase (ALT) and Aspartate Transiminase (AST) ≤ 5 × ULN;; Total bilirubin ≤ 1.5 x ULN with the exception of patients with Gilbert syndrome ...

8. A Study to Evaluate Intravenous Ascorbic Acid (Vitamin C) as an Adjunct to Pazopanib in the First-Line or Post-immunotherapy Setting for Metastatic or Unresectable Clear Cell Renal Cell Carcinoma (ccRCC) - Mayo Clinic

   Alanine amino transferase (ALT) < 2.5 X ULN, with normal bilirubin. ... NOTE: Concomitant elevations in bilirubin and ALT above 1.5 x ULN (upper limit of normal) ...

9. A Study of TAS-120 in Patients With Metastatic Breast Cancer - Mayo Clinic

   ... ALT ≤ 5 × ULN;; Total bilirubin ≤ 1.5 × ULN or ≤ 3 × ULN in case of Gilbert's syndrome;; Absolute neutrophil count (ANC) ≥ 1.0 × 10^9/L without ...

10. A Study To Evaluate the Effect of Canakinumab or Pembrolizumab Given as Monotherapy or in Combination as Neo-adjuvant Treatment for Subjects With Early Stages NSCLC - Mayo Clinic

    Alanine transaminase (ALT) ≤ 3 x ULN;; Serum amylase ≤ 2 x ULN or pancreatic amylase ≤ 1.5 x ULN. Subject must have adequate cardiovacular and respiratory ...